Future mechanistic studies are warranted to confirm the molecular basis of the decreased KIR3DL1+HLA-Bw4+ and KIR3DL2+HLA-A3/11+ gene combinations in dampening the effector functions of NK cells in COVID-19 patients. This evidence concerns the gene KIR3DL2 and COVID-19.